The use of revascularization strategies in patients with acute coronary syndromes admitted to hospitals without catheterization facilities: Results from the ALERT-CZ registry

Petr Widimský, Jana Zvárová, Zdeněk Monhart, Petr Janský

Cor Vasa 2013, 55(3):e207-e211 | DOI: 10.1016/j.crvasa.2013.04.007  

Aim: Percutaneous coronary intervention (PCI) became the standard of care for patients (pts) with acute coronary syndromes (ACS). The Czech Republic is among European countries with well developed networks of PCI and non-PCI hospitals. Ample data about PCI-treated pts is available from many registries. Much less is known about treatments and outcomes of ACS pts admitted to hospitals without cath-lab. ALERT-CZ registry was designed specifically to analyze these patients presenting to local non-PCI hospitals. The aim was to see, whether the ESC guidelines are implemented in these local, small hospitals.Methods and results: A total of 6265 pts with...

Could severity of mitral annular calcification predict other left sided structural or functional abnormalities?

Ahmed M. Abdel-Salam, Mohamed Abdel-Zaher Abdallah

Cor Vasa 2013, 55(3):e212-e216 | DOI: 10.1016/j.crvasa.2013.03.013  

Objective: The prognostic value of MAC severity is important not only because it shares common risk factors with vascular atherosclerotic changes but also through increasing the cardiovascular morbidity and mortality. This study was conducted in order to evaluate association between severity of MAC and left sided echocardiographic abnormalities mainly left sided valvular abnormalities as well as left atrial systolic and diastolic functional abnormalities.Methods: We prospectively obtained 12-lead electrocardiograms and transthoracic echocardiograms (TTE) on patients scheduled for non-emergent echocardiographic assessment at tertiary care hospital....

Isolated non-compaction cardiomyopathy: A review

Renata Virtová, Miloš Kubánek, Marek Šramko, Luděk Voska, Dana Kautznerová, Josef Kautzner

Cor Vasa 2013, 55(3):e236-e241 | DOI: 10.1016/j.crvasa.2012.11.001  

Homocysteine and venous thromboembolism- Is there any link?

Jana Hirmerová

Cor Vasa 2013, 55(3):e248-e258 | DOI: 10.1016/j.crvasa.2013.01.007  

Homocysteine is an intermediary product of methionine metabolism. The level of homocysteine is controlled by two pathways - remethylation and transsulphuration. Elevated homocysteine level may result from deficiency or impaired function of enzymes and cofactors in these pathways. Homocystinuria is a rare genetic disease with extreme hyperhomocysteinemia and is associated with the occurrence of arterial and venous thrombotic events at young age. Therefore, homocysteine has been considered as a risk factor for vascular diseases.Plasma homocysteine level is influenced by many factors, genetic as well as environmental. Mild hyperhomocysteinemia is...

Coronary artery ectasia

Ozgur Ulas Ozcan, Sadi Gulec

Cor Vasa 2013, 55(3):e242-e247 | DOI: 10.1016/j.crvasa.2013.01.003  

Coronary artery ectasia (CAE) is defined as localized or diffuse dilation of coronary artery lumen exceeding the largest diameter of an adjacent normal vessel more than 1.5 fold. The incidence of CAE is reported as 0.3-4.9% of patients undergoing coronary angiography. The rate of recognition may increase with the use of new non-invasive imaging methods as computed tomography (CT) and magnetic resonance (MR) coronary angiography. Atherosclerosis is considered as the main etiologic factor responsible for more than 50% of cases in adults while Kawasaki disease is the most common cause in children or young adults. Coronary ectasia is thought to be a result...

Arterial hypertension and chronic heart failure

Filip Málek

Cor Vasa 2013, 55(3):e259-e263 | DOI: 10.1016/j.crvasa.2013.04.002  

Third universal definition of myocardial infarction

Jan Vojáček, Petr Janský, Tomáš Janota

Cor Vasa 2013, 55(3):e228-e235 | DOI: 10.1016/j.crvasa.2012.12.004  

Partial subacute thrombosis of drug eluting stent in CT coronarography and IVUS image

Leoš Pleva, Tomáš Jonsta, Peter Blaško, Petr Berger, Pavel Kukla

Cor Vasa 2013, 55(3):e264-e270 | DOI: 10.1016/j.crvasa.2012.09.003  

Coincidence of bicuspid aortic valve presence and hypertrophic cardiomyopathy, and significance of magnetic resonance in its diagnostics

Branislav Obžut, Peter Blaško, Martin Porzer

Cor Vasa 2013, 55(3):e271-e276 | DOI: 10.1016/j.crvasa.2012.09.004  

Biventricular Takotsubo syndrome in a patient with coronary abnormality and end-stage renal disease

Ferit Onur Mutluer, Rosalinda Madonna, Cihan Cevik, Maher M. Nasser, Raffaele De Caterina

Cor Vasa 2013, 55(3):e277-e280 | DOI: 10.1016/j.crvasa.2012.09.005  

The Takotsubo syndrome is a clinical entity consisting of transient, regional left ventricular (LV) contraction abnormalities in the absence of significant epicardial coronary artery disease. Patients usually present with acute hemodynamic deterioration following an emotional or physical stress. The Takotsubo syndrome is uncommon among patients with end-stage renal disease (ESRD) and patients with congenital coronary abnormalities, such as right coronary artery (RCA) originating from left sinus of Valsalva. Here we describe a patient presenting with acute respiratory distress and anterolateral ST-T segment changes, with negative troponin-I and elevated...

Contribution of remote monitoring to the early diagnosis of implantable cardioverter-defibrillator shocks in the patient with cardiac resynchronisation therapy

Klaudia Židová, Miroslav Novák, Jolana Lipoldová

Cor Vasa 2013, 55(3):e281-e284 | DOI: 10.1016/j.crvasa.2012.12.003  

Assessing cardiac patients for fitness to drive motor vehicles. Expert consensus statement of the Czech Society of Cardiology-2012 update

Jaromír Hradec, Miloš Táborský, František Toušek, Hana Skalická

Cor Vasa 2013, 55(3):e217-e224 | DOI: 10.1016/j.crvasa.2013.04.005  

Acute coronary syndromes with ongoing myocardial ischemia (ACS with OMI) versus acute coronary syndromes without ongoing ischemia (ACS without OMI). The new classification of acute coronary syndromes should replace old classification based on ST segment elevation presence or absence-Expert consensus statement of the Czech Society of Cardiology

Petr Widimský, Richard Rokyta, Josef Šťásek, Jan Bělohlávek, Pavel Červinka, Petr Kala

Cor Vasa 2013, 55(3):e225-e227 | DOI: 10.1016/j.crvasa.2013.04.008  

Apixaban: kvalitní možnost nejen pro pacienty, jimž se bojíme podávat warfarin

Cor Vasa 2013, 55(3):354-355  

Kardiovaskulární riziko u pacientů s chronickým onemocněním ledvin a možnosti jeho ovlivnění

MUDr. Zuzana Zafarová

Cor Vasa 2013, 55(3):356-358  

13. komnata fibrilace síní? Ischemická cévní mozková příhoda!

Cor Vasa 2013, 55(3):360-363  

Specifické populace se STEMI a jejich léčba

MUDr. Zuzana Zafarová

Cor Vasa 2013, 55(3):364-366  

V. sjezd České společnosti kardiovaskulární chirurgie s mezinárodní účastí v Brně

Prof. MUDr. Jan Černý, CSc., prof. MUDr. Robert Staffa, Ph.D.

Cor Vasa 2013, 55(3):350-353 | DOI: 10.33678/cor.2013.025  

Zpráva z 2. kongresu International Society for Vascular Surgery

MUDr. Robert Vlachovský, Ph.D.

Cor Vasa 2013, 55(3):353 | DOI: 10.33678/cor.2013.026  

Zápis ze schůze výboru ČKS konané dne 26. 2. 2013 v Praze

P. Widimský, P. Riebauerová

Cor Vasa 2013, 55(3):367-368  

Evidence v medicíně. Komentář k současné koncepci klinických studií a jejich prospěšnosti

Pavel Jerie

Cor Vasa 2013, 55(3):346-349 | DOI: 10.33678/cor.2013.023  

Editorial Board

Editorial board

Cor Vasa 2013, 55(3):i | DOI: 10.1016/S0010-8650(13)00069-6  

BIOMEDICAL PAPERS 157(1), 2013 (Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013 March;157(1):1-89)

Prof. MUDr. Vilím Šimánek

Cor Vasa 2013, 55(3):349